iBio, Inc. announced positive preclinical results from an eight-week obese non-human primate study showing that their antibody drug IBIO-610, combined with semaglutide, preserved muscle mass better than semaglutide alone. The combination resulted in 93% of weight loss from fat versus 77% with semaglutide alone. IBIO-610 also demonstrated a long half-life, potentially allowing twice-yearly dosing. iBio plans to start first-in-human trials of IBIO-610 in the first half of 2027, aiming to offer a new therapeutic option for obesity and cardiometabolic diseases.
iBio's IBIO-610 drug shows promising preclinical results for muscle preservation in combination with GLP-1 therapy. For readers following the health sector, here is Pluang's market snapshot as of Oct 13, 2026 16:51 WIB: out of 128 priced US health stocks, 80 rose and 41 fell. Notable movers include Cytokinetics Inc (CYTK) at USD 61.86 with a 1-day change of -1.48% and a typical hold time of 19 days, Alcon AG (ALC) at USD 65.28 with a 1.45% increase and 100% buy order activity, and Ginkgo Bioworks Holdings Inc (DNA) at USD 11.62 with a -1.44% change and 65% buy order activity.
Foresight Autonomous Holdings has signed a non-binding term sheet to acquire a 50.01% controlling interest in a company developing two data center projects in Warsaw and Wroclaw, Poland, with a combined planned capacity of 270 MW. This move aligns wi...
YieldMax ETFs declared weekly distributions for their Group 1 ETFs, with payment on October 15, 2026. The distributions vary by ETF, reflecting different distribution rates and 30-day SEC yields, ranging from about 23% to over 60%. These ETFs cover s...
The Asia-Pacific sustainable data center market is projected to grow from $16.74 billion in 2025 to $57.18 billion by 2031, at a CAGR of 22.7%. Growth is fueled by rising demand for AI, cloud computing, and hyperscale infrastructure, prompting invest...
Holafly has introduced the Ultra Plan, a new global eSIM subscription that offers unlimited mobile data alongside health and wellness services, including 24/7 medical messaging, mental health sessions, nutrition and fitness coaching, and veterinary a...
Select Water Solutions announced its subsidiary will offer $800 million in senior notes due 2034 to qualified institutional buyers, aiming to fund part of its acquisition of Pilot Water Solutions, repay existing debt, and cover related costs. The not...
